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Previously we described the antinociceptive effect of magnesium sulfate and dizocilpine (MK-801) in the visceral and somatic rat models 
of pain. In the somatic model of pain, we established the influence of selective inhibitors of neuronal and inducible nitric oxide synthase 
on the antihyperalgesic effects of magnesium sulfate and dizocilpine. Therefore, the objective of the present study was to determine in 
the rat model of visceral pain whether same mechanisms are involved in the antinociceptive action of magnesium sulfate and dizocilpine. 
Analgesic activity was assessed using the acetic acid-induced writhing test in rats. Subcutaneous injection of either magnesium sulfate 
(15 mg/kg) or dizocilpine (0.01 mg/kg) decreased the number of writhes by about 60 and 70%, respectively. The role of nitric oxide on the 
effects of magnesium sulfate and dizocilpine was evaluated using selective inhibitor of neuronal [N-ω-Propyl-L-arginine hydrochloride 
(L-NPA)] and inducible [S-methylisothiourea (SMT)] nitric oxide synthase, which per se did not affect the number of writhes. We observed 
that the antinociceptive effect of magnesium sulfate or dizocilpine did not change in the presence of L-NPA (2 and 10 mg/kg, i.p.) and SMT 
(0.015 and 10 mg/kg, i.p.). We conclude that, nitric oxide produced by neuronal and inducible nitric oxide synthase does not modulate the 
effects of magnesium sulfate and dizocilpine in the visceral inflammatory model of pain in the rat.
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INTRODUCTION
Intraperitoneal injection of acetic acid serves an 
animal model for acute and tonic visceral pain in the rat 
(Mogil et al. 1996). Acetic acid induces inflammation in 
the peritoneum, causing a writhing response. Writhing 
includes a stereotypic response pattern characterized by 
constrictions composed of abdominal contractions, twisting 
and turning of the trunk and extension of the hind limbs. 
A complex network of signaling molecules mediates the 
perception of visceral pain. The intraperitoneal injection of 
acetic acid is followed by the activation of chemosensitive 
nociceptor or irritation of the visceral surface, which leads 
to the release of histamine, bradykinin, prostaglandins and 
serotonin, which (García et al. 2004) produce the sensation 
of pain. The role of N-methyl-D-aspartate (NMDA) receptors 
and nitric oxide in the modulation of visceral pain has also 
been shown (Li et al. 2004, Willert et al. 2004, Strigo et al. 
2005).
The writhing assay is a nonspecific but sensitive method 
widely used as a screening test to assess the analgesic or 
anti-inflammatory properties of new compounds (Le Bars 
et al. 2001). This test is sensitive to opioid and nonsteroidal 
anti-inflammatory drugs (NSAIDs) that act through 
a central and peripheral mechanisms. Given that the use of 
these drugs is accompanied by side effects, it is necessary 
to develop novel analgesics with less side effects. Previous 
experiments conducted in our laboratory demonstrated 
the analgesic effect of magnesium sulfate and dizocilpine 
(MK-801) in different models of nociception, such as the 
carrageenan-induced somatic (Srebro et al. 2014a, 2014b) 
and acetic acid-induced visceral inflammatory pain models 
(Vučković et al. 2015). However, the mechanisms responsible 
for the effects of magnesium and dizocilpine remain 
unknown. Nitric oxide is a controversial molecule with dual 
effects, pronociceptive and antinociceptive (Zhuo et al. 1993, 
Abacioğlu et al. 2000). There is evidence that inflammatory 
somatic and visceral pain is associated with nitric oxide 
(Zhuo et al. 1993, Abacioğlu et al. 2000). We proposed 
that nitric oxide and cyclic guanosine monophosphate 
(cGMP)/adenosine triphosphate (ATP)-sensitive K+ channel 
(K+ATP) pathways play an important role in the modulation 
of antihyperalgesic/antinociceptive effects of magnesium 
sulfate and dizocilpine in somatic and visceral models of 
pain. Using a model of visceral inflammatory pain in the rat, © 
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our aim was to determine whether a nitric oxide-dependent 
mechanism is responsible for in the antinociceptive action 
of magnesium sulfate and dizocilpine in this model of pain 
in the rat. To that end, we used the selective inhibitor of 
neuronal [N-ω-Propyl-L-arginine hydrochloride (L-NPA)] 
and inducible [S-methylisothiourea (SMT)] nitric oxide 
synthase.
MATERIALS AND METHODS
Subjects
The experiments were carried out on 120 adult male 
Wistar rats (250–300 g) obtained from the Military Medical 
Academy (Belgrade, Serbia). The animals were housed in 
groups of three per cage (42.5×27×19 cm) under standard 
conditions of temperature (22±1°C), relative humidity (60%) 
and light/darkness (12 h, respectively) cycle. Food and water 
were available ad libitum, except during the experimental 
procedure. The animals were fed with standard rat pellet 
feed obtained from the Subotica Veterinary Institute, 
Serbia. All experiments were performed at the same 
time of day (between 8:00 and 16:00 h) to avoid diurnal 
variations in the behavioral tests. All experimental groups 
were comprised of 6 rats. Each animal was used only once 
and was killed at the end of the experiments with an i.p. 
injection of sodium thiopental (200 mg/kg).
Ethical statement
The research was approved by the Ethics Committee for 
Animal Research and Welfare of the Faculty of Medicine, 
University of Belgrade (permission N° 4946/2 and 5362/2). 
All experiments were approved by the Ethical Council for 
the Protection of Experimental Animals of the Ministry 
of Agriculture, Forestry and Water Management of the 
Republic of Serbia, which operates in accordance with the 
Animal Welfare Law of Serbia and the European Community 
Council Directive for the Care and Use of Laboratory 
Animals from November 24, 1986 (86/609/EEC).
Experimental procedure
Experimental model of visceral nociception 
The acetic acid-induced writhing test in rats served as the 
model for visceral nociception. The experimental procedure 
was performed as described previously (Al-Mamun et al. 
2011, Vučković et al. 2015). Briefly, before the induction of 
writhing, the animals were placed in individual cages and 
acclimatized to the laboratory conditions. The writhing 
response was elicited by an intraperitoneal (i.p.) injection 
of 0.7% acetic acid solution (10 ml/kg body weight). The 
number of writhes was counted during a 20-min period, 
starting 5 min after administration of the acetic acid. 
The reduction in the number of abdominal contractions 
compared to the control was considered as an analgesic 
response.
Calculations used in the experimental model of visceral pain
The number of writhes in each treated group was 
compared with a control (saline-treated group); the 
treatments that produced a significant decrease in 
the number of writhing events were considered to be 
antinociceptive. Analgesic activity (AA%), expressed as 
the percentage decrease in the number of writhes in each 
rat was calculated according to the formula (Vučković et 
al. 2015): %AA=[(Wc–Wt)/Wc]×100, where Wc is the average 
number of abdominal contractions in the control group 
and Wt is the number of abdominal contractions observed 
in each rat in the tested group.
Drugs and their administration 
Magnesium sulfate (Magnesio Solfato; S.A.L.F. Spa-Cenate 
Sotto-Bergamo, Italy), MK-801 [(+)-MK-801 hydrogen 
maleate, dizocilpine maleate; Sigma-Aldrich, St. Louis, MO, 
USA], N-ω-Propyl-L-arginine hydrochloride [L-NPA; Tocris 
Bioscience, Bristol, UK), S-methylisothiourea (SMT, Tocris 
Bioscience, Bristol, Great Britain) and acetic acid (pure 
refined 80% acetic acid; MSK Kikinda, Serbia) were dissolved 
in saline. All drugs used were injected at a final volume of 
2 ml/kg (or 10 ml/kg for acetic acid].
The following protocol was used for drug administration: 
magnesium sulfate or MK-801 was administrated 
subcutaneously (s.c.) 15 min before the injection of acetic 
acid. L-NPA or SMT were administrated (i.p.) 10 min before 
the magnesium sulfate/dizocilpine. To test whether the 
injection of L-NPA or SMT had any effect on the number of 
writhes (analgesic activity) in the acetic acid-treated rats, 
the same volumes of these compounds were administered 
to a separate group of rats. Control rats in all groups 
received the corresponding volume of the vehicle.
Statistical analysis
The data are presented as mean difference in number 
of writhing ±standard error of the mean (SEM) obtained 
by testing in six rats. Differences between corresponding 
means were verified by using Kruskal-Wallis test, followed 
by Mann-Whitney (U) test. A P value of less than 0.05 was 
considered statistically significant.
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RESULTS
The influence of L-NPA on the effect of magnesium 
sulfate in the acetic acid-induced writhing test
Magnesium sulfate administered subcutaneously (s.c.) 
at a dose of 15 mg/kg significantly (p=0.002) decreased the 
number of writhes movements by 59.9±7%. Doses of L-NPA 
(2 and 10 mg/kg, i.p.), which did not per se affect writhing, 
also did not affect (p>0.05) the antinociceptive effect of 
magnesium sulfate (15 mg/kg, s.c.) (Fig. 1).
The influence of SMT on the effect of magnesium 
sulfate in the acetic acid-induced writhing test
There was no statistical significance (p>0.05) between 
the antinociceptive effects of magnesium sulfate (15 mg/kg, 
s.c.) and magnesium sulfate in combination with SMT (0.015 
and 10 mg/kg, i.p.) (Fig. 2). When compared with saline, 
magnesium sulfate given alone, or in combination with 
either 0.015 or 10 mg/kg SMT (i.p.) – significantly (p=0.002) 
decreased the number of writhes by 67.9±6.0, 61.1±7.0 and 
62.1±6.9%, respectively. The same doses of SMT (0.015 
and 10 mg/kg, i.p.) administered alone did not affect the 
number of writhes. SMT at a dose as high as 25 mg/kg (i.p.) 
significantly (p=0.021) reduced the number of writhes in 
rats by 52.5±10.9% (but it is not here).
The influence of L-NPA on the effect of dizocilpine 
in the acetic acid-induced writhing test
Dizocilpine, given alone or in combination with 
L-NPA, significantly (p=0.002) decreased the number 
of writhing in rats (Fig. 3). The antinociceptive 
effect of dizocilpine (0.01 mg/kg, s.c) did not change 
with L-NPA (2 and 10 mg/kg, i.p.), which did not per 
se cause any writhing. The antinociceptive effects 
in this combination were manifested as decreases 
in the number of writhes to 73.2±6 and 68.8±5.2%, 
respectively.
The influence of SMT on the effect of dizocilpine in 
the acetic acid-induced writhing test
As shown in Fig. 4, dizocilpine (0.01 mg/kg, 
s.c) significantly (p=0.002) decreased the number 
of writhes in rats by 71.8±5.8%. Dizocilpine, in 
combination with the same doses of SMT, had similar 
and significant (p=0.002) antinociceptive effects, 
manifested as decreases in the number of writhes 
to 70.9±6.8 and 75.7±4.3%. In control rats, SMT given 
alone at doses of 0.015 and 10 mg/kg – i.p. did not 
influence (p>0.05) the writhing episodes after 
injection of acetic acid in rats.
Fig. 1. Effect of L-NPA (2 and 10 mg/kg, i.p.) on the antinociceptive effect 
of magnesium sulfate (MS 15 mg/kg, s.c.) in acetic acid-induced writhing 
test. Each bar represents the mean ±SEM for a group of 6 rats, analyzed by 
Kruskal-Wallis test, followed by Mann-Whitney (U) test. **p<0.01 vs. saline 
group. s.c., subcutaneous, i.p., intraperitoneal.
Fig. 2. Effect of SMT (0.015 and 10 mg/kg, i.p.) on the antinociceptive effect 
of magnesium sulfate (MS 15 mg/kg, s.c.) in acetic acid-induced writhing 
test. Each bar represents the mean ±SEM for a group of 6 rats, analyzed by 
Kruskal-Wallis test, followed by Mann-Whitney (U) test. **p<0.01 vs. saline 
group. s.c., subcutaneous, i.p., intraperitoneal.
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DISCUSSION
In this study, we observed that the antinociceptive 
effects of magnesium sulfate and dizocilpine in the visceral 
inflammatory model of pain were not reverted by the 
inhibition of neuronal and inducible nitric oxide synthase. 
This result is contrary to the finding we obtained in the 
somatic inflammatory model of pain.
The writhing test serves as model of acute visceral 
pain and has been suggested as a clinically relevant model 
for intestinal pain in humans (Reichert et al. 2001). We 
previously reported that both magnesium sulfate and 
dizocilpine produce an analgesic effect in the writhing test, 
without inducing central nervous system (CNS) side effects. 
Magnesium sulfate and dizocilpine displayed biphasic and 
linear dose-response patterns, respectively (Vučković et 
al. 2015). Dizocilpine is a non-competitive NMDA receptor 
antagonist and blocks NMDA-induced currents in a voltage-
dependent manner, preventing the influx of calcium ions 
through the channel (Kovacic and Somanathan 2010). 
Magnesium, in addition to exerting other effects, is an 
endogenous, noncompetitive, voltage-dependent NMDA 
receptor-channel blocker (Fawcett et al. 1999, Herroeder 
et al. 2011). It has been documented that magnesium in 
different formulations (magnesium sulfate, magnesium 
oxide and magnesium oxide nanoparticles) can either 
produce or not produce an antinociceptive effect in the 
acetic acid-induced writhing test (Assi 2001, Jahangiri 
et al. 2013). Literature data suggest that both dizocilpine 
(Suardíaz et al. 2007) and ketamine (Bulutcu et al. 
2002, Mohammad et al. 2012) decrease the number of 
writhes in a dose-dependent manner. Ketamine acts as a 
noncompetitive NMDA receptor antagonist (Øey 1998). 
We propose that the NMDA-dependent mechanism is 
involved in the antinociceptive effects of dizocilpine, 
and in part, of magnesium sulfate. This is in agreement 
with the view that NMDA receptors are peripherally and 
centrally expressed and involved in nociceptive visceral 
input processing (Li et al. 2004, Willert et al. 2004, Strigo 
et al. 2005). It has been shown that glutamate receptors are 
present in the stomach, duodenum and descending colon 
in the rat (Burns et al. 1994) and, that they play a role in 
intestinal motility and inflammation (Varga et al. 2010). 
Also, it was suggested that in hypothyroid rats changes in 
the distribution of NMDA receptors in the hippocampal 
neurons contributed to DNA damage and apoptosis and 
this effect is prevented by the dizocilpine (Alva-Sanchez 
et al. 2014). Since dizocilpine and magnesium block NMDA 
receptor activation by distinct mechanisms of action, and 
as dizocilpine is a NMDA antagonist, while magnesium has 
other mechanisms of action, it is expected that their effects 
are to a certain extent different (Salińska and Lazarewicz 
1995). In the in vivo animal model of pain, we showed that 
magnesium activates the transient receptor potential 
ankyrin 1 (TRPA1) channels at the local peripheral level 
(Srebro et al. 2015). An electrophysiological study has 
shown that the activation the TRPA1 receptors in the 
spinal dorsal horn has an antinociceptive effect (Yamanaka 
et al. 2015). In accordance with this, we speculate that 
magnesium could activate TRPA1 receptors in the CNS, 
contributing to pain reduction of pain, while at the 
periphery it contributes to local hyperalgesia (Srebro et 
al. 2015). TRPA1 receptors are involved in the development 
of both somatic and visceral inflammatory pain (Eid et al. 
2008, Pereira et al. 2013). HC-030031, a selective TRPA1 
receptor antagonist, attenuated visceral nociception by 
Fig. 3. Effect of L-NPA (2 and 10 mg/kg, i.p.) on the antinociceptive effect of 
dizocilpine (MK-801, 0.01 mg/kg, s.c.) in acetic acid-induced writhing test. 
Each bar represents the mean ±SEM for a group of 6 rats, analyzed by 
Kruskal-Wallis test, followed by Mann-Whitney (U) test. **p<0.01 vs. saline 
group. s.c., subcutaneous, i.p., intraperitoneal.
Fig. 4. Effect of SMT (0.015 and 10 mg/kg, i.p.) on the antinociceptive effect 
of dizocilpine (MK-801, 0.01 mg/kg, s.c.) in acetic acid-induced writhing 
test. Each bar represents the mean ±SEM for a group of 6 rats, analyzed by 
Kruskal-Wallis test, followed by Mann-Whitney (U) test. **p<0.01 vs. saline 
group. s.c., subcutaneous, i.p., intraperitoneal.
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a mechanism independent of the modulation of nitric 
oxide and opioid pathways (Pereira et al. 2013). 
It is known that nitric oxide is involved in somatic 
and visceral pain modulation, both in the CNS and 
peripheral nervous systems, in somatic and visceral 
pain (Bulutcu et al. 2002, Freire et al. 2009, Srebro et al. 
2014a, 2014b). Nitric oxide plays both nociceptive and 
antinociceptive roles. Because the synthesis of nitric oxide 
by constitutive nitric oxide synthase enzymes is calcium- 
and calmodulin-dependent and NMDA receptors are 
permeable for calcium ions, it is possible that nitric oxide 
is activated through the NMDA receptors. In accordance 
with this preconditioning of the cerebellar granule cells 
in primary culture by 30-minute exposure to dizocilpine 
or memantine, NMDA receptor antagonists, might induce 
tolerance to event associate with glutamate-induced 
increase in intracellular calcium levels (Słomka et al. 
2014). Previously, we found that nitric oxide modulates 
the antihyperalgesic effects of magnesium sulfate and 
dizocilpine in somatic pain in a different manner. Only at 
the highest tested doses did we observe a decrease of the 
antihyperalgesic effect of magnesium sulfate with the 
selective inhibitors of neuronal (L-NPA) and inducible (SMT) 
nitric oxide synthase (Srebro et al. 2014a). With inhibitor 
of neuronal nitric oxide synthase, we observed an increase 
in the antihyperalgesic effect of dizocilpine, whereas SMT, 
a selective inhibitor of the inducible nitric oxide synthase, 
lowered the antihyperalgesic effect of dizocilpine (Srebro 
et al. 2014b). In the present study, we examined how the 
same and higher doses of nitric oxide synthase inhibitors 
affect the antinociceptive effects of magnesium sulfate 
and dizocilpine in the visceral model of pain. Contrary 
to our expectations, the selective inhibitors of nitric 
oxide synthase had no influence on the antinociceptive 
effects of magnesium sulfate and dizocilpine. A possible 
explanation is that different mechanisms contribute to 
the antinociceptive effects of both magnesium sulfate and 
dizocilpine in somatic and visceral pain. Also, visceral and 
somatic pain exhibit differences in the neurobiological 
mechanisms that mediate the sensory process. 
Something can be similar because visceral pain can be 
“true” visceral pain and referred visceral pain which is 
“convergence-projection” combination of viscero-somatic 
neurons (Cervero 1985). Bearing in mind the differences 
between somatic and visceral pain models, we used higher 
doses of antagonists to examine the involvement of nitric 
oxide in the analgesic action of magnesium sulfate and 
dizocilpine. With a five-fold higher dose of L-NPA we did 
not observe a significant influence on the antinociceptive 
effects of either magnesium sulfate or dizocilpine. L-NPA 
is highly a selective and potent inhibitor of neuronal 
nitric oxide synthase, displaying 3158- and 149-fold 
higher selectivity on inducible and endothelial nitric 
oxide synthases, respectively. Also, the higher dose of SMT 
(10 mg/kg, i.p.) did not change the antinociceptive effects 
of magnesium sulfate and dizocilpine. In our previous 
study, SMT, an inducible nitric oxide synthase inhibitor, 
was effective at a later time-point than L-NPA (Srebro et al. 
2014a, 2014b). It is possible that the short duration of the 
observation period is the reason why we obtained different 
results those reported in our previous study. In addition, it 
was shown that the selective inhibitor of inducible nitric 
oxide synthase produces an antinociceptive effect in the 
acetic-acid writhing test, suggestions that the nitric oxide 
produced by the inducible nitric oxide synthase plays a 
role in pain processing (LaBuda et al. 2006). It was shown 
that SMT has a dose-dependent analgesic effect in the 
formalin-induced pain model as soon as 15–30 min after 
formalin injection (Bhat et al. 2008). Moreover, the dose 
of SMT (25 mg/kg, i.p.) that did not reduce the late phase 
(15–30 min) of formalin-induced pain behavior (Bhat et al. 
2008), induced a 50% reduction in the number of writhes in 
the model used herein.
We previously reported that L-NAME, a non-selective 
inhibitor of nitric oxide synthase, does not reduce the 
antinociceptive effect of magnesium sulfate in the same 
visceral pain model (Vučković et al. 2015). However, L-NAME 
eliminates the antihyperalgesic effect of dizocilpine 
(Vučković et al. 2015). In light of the presented finding, the 
most likely explanation for the inhibitory role of L-NAME 
on the antinociceptive effect of dizocilpine, as, reported in 
our previous study (Vučković et al. 2015), is that L-NAME 
decreased the delivery of dizocilpine to the brain, perhaps 
as a result of the effect of L-NAME-induced alterations in 
blood flow. Mueller and Hunt (1998) reported that L-NAME, 
due to pharmacokinetic interaction, decreased the delivery 
of ketamine into rat brain and reduced behavioral response 
to ketamine. In addition, an in vitro study demonstrated 
that ketamine had no direct effect on nitric oxide synthase 
activity (Tobin et al. 1994). As regards magnesium sulfate, 
it was reported that it increases the velocity of cerebral 
blood flow (Ludbrook et al. 1999) and significantly reduces 
L-NAME-induced hypertension in pregnant rats (Standley 
et al. 2006).
The present study shows that in an acetic acid-induced 
visceral pain model in the rat, the analgesic effects 
of magnesium, a non-typical NMDA antagonist, and 
dizocilpine, a referent NMDA antagonist, do not depend on 
nitric oxide production.
CONCLUSIONS
Research efforts have focused on investigations 
of analgesic drugs that may serve as be alternatives 
to NSAIDs and opiates which produce unwanted side 
effects. Magnesium sulfate and dizocilpine could be used 
as adjuvant analgesics. Dizocilpine is not used clinically 
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because of its side effects. It is used as a reference drug 
in the investigations of the NMDA receptors. The exact 
mechanisms involved in the antinociceptive effect of 
magnesium sulfate or dizocilpine in the visceral model of 
inflammatory pain are not known. Here, we have shown 
that nitric oxide produced by neuronal and inducible 
nitric oxide synthase does not modulate their effects in the 
visceral inflammatory model of pain. More experiments 
are needed to clarify their mechanisms.
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